Clinical Trial Update: Prasugrel in Severe COVID-19 Pneumonia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for prasugrel in severe COVID-19 pneumonia with thrombosis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombosis

Drugs mentioned

• PRASUGREL (prasugrel)

Snippet

Sponsor: Azienda Ospedaliera Universitaria Integrata Verona | Conditions: COVID19, Thrombosis | Phase 3 | Status: UNKNOWN